New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development

SIMPLE SUMMARY: Innovative advancements in lung cancer treatment have developed over the past decade with the advent of targeted and immune therapies. Yes-associated protein (YAP), an effector of the Hippo pathway, promotes the resistance of these targeted drugs and modulates tumor immunity in lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Geon, Park, Dongil, Kim, Yoonjoo, Chung, Chaeuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234989/
https://www.ncbi.nlm.nih.gov/pubmed/34202980
http://dx.doi.org/10.3390/cancers13123069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234989/
https://www.ncbi.nlm.nih.gov/pubmed/34202980
http://dx.doi.org/10.3390/cancers13123069

Ejemplares similares